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Amyloidosis is a clinical disorder implicated with the formation of toxic amyloid aggregates. Despite their
pathological signiﬁcance, it is challenging to deﬁne the structural characteristics of amyloid oligomers
owing to their metastable nature. Herein, we report structural and mechanistic investigations of human
islet amyloid polypeptide (hIAPP) oligomers, found in type II diabetes mellitus, in both the absence and
presence of disease-relevant metal ions [i.e., Cu(II) and Zn(II)]. These metal ions show suppressive eﬀects
on hIAPP ﬁbrillation and facilitate the generation of toxic oligomers. Using circular dichroism
spectroscopy, transmission electron microscopy, gel electrophoresis, small-angle X-ray scattering, and
ion mobility-mass spectrometry, we investigated the assembly mechanisms of hIAPP oligomers in the
presence and absence of metal ions. Oligomerization of both metal-free hIAPP and metal-associated
hIAPP monomers is initiated following a similar growth model. However, in the presence of Cu(II), hIAPP
monomers self-assemble into small globular aggregates (Rg  45 A˚) with a random coil structure. This
Cu(II)-associated hIAPP oligomer shows an oﬀ-pathway aggregation, and is suggested to be an end
product which is toxic to pancreatic b-cells. On the other hand, metal-free hIAPP and Zn(II)-associated
hIAPP monomers generate relatively less toxic aggregates that eventually grow into ﬁbrils. We suggest
that the coordination of hIAPP to Cu(II) and the relatively high stability (Ka, ca. 10
8 M1) of hIAPP–Cu(II)
complexes result in the abnormal conformation and toxicity of hIAPP oligomers. Overall, through
combining multiple biophysical methods, our studies suggest that molecular interactions between hIAPP
and Cu(II) induce a diﬀerent pathway for hIAPP assembly. This work will advance our knowledge of the
conformational basis, assembly mechanism, and toxicity of small soluble amyloid oligomers.Introduction
Amyloid oligomers have generally been considered as the major
toxic species in the pathogenesis of amyloidosis.1,2 In particular,
small-sized, soluble oligomers that are formed at the early onset
of amyloidosis cause more severe cellular deterioration
compared to soluble protein monomers or insoluble brils.2
Despite the signicance of the soluble oligomers in amyloid-
osis, it is still challenging to characterize the conformation of
the oligomers and their correlation to cytotoxicity due to theirl Institute of Science and Technology
-mail: mhlim@unist.ac.kr
y of Science and Technology (POSTECH),
te for Natural Sciences, Korea University,
hkim@korea.ac.kr
Yokohama City University, Yokohama,
(ESI) available: Experimental section,
I: 10.1039/c6sc00153j
is work.structural heterogeneity and metastable characteristics.1 One of
the practical strategies is to adopt specic conditions for
stabilizing oligomeric states3 or use segments of amyloidogenic
proteins which present slow brillation kinetics relative to the
whole protein.4 To date, however, only limited information on
soluble oligomers of full-sequence amyloid proteins is available
due to the complex behavior of these proteins. Therefore,
multiscaled approaches are required to elucidate the structural
features and assembly characteristics of the soluble oligomers.
Aggregates of human islet amyloid polypeptide (hIAPP,
Fig. 1a), found in the pancreatic b-cells of type II diabetes
mellitus (T2DM) patients, are observed to be linked to T2DM
pathogenesis.5 To explain the link between hIAPP aggregates
and T2DM, several hypotheses regarding the toxicity of hIAPP
oligomers have been put forward, including reactive oxygen
species (ROS) generation,6,7 membrane destabilization,8,9 auto-
phagy dysfunction,10 disruption of cell-to-cell interactions,11
and secretory granules.12 Although potential toxicity mecha-
nisms of hIAPP oligomers have been suggested, the mechanism
of hIAPP oligomer formation remains elusive.This journal is © The Royal Society of Chemistry 2016
Fig. 1 Analysis of hIAPP oligomers by CD and TEM. (a) The sequence of hIAPP. (b) CD spectra of metal-treated and metal-free hIAPP solution
after 0 h (top) and 6 h (bottom) incubation. (c) TEM images of hIAPP aggregates. Cu(II) induces the formation of non-ﬁbrillar aggregates, while
Zn(II)-treated and metal-free hIAPP form amyloid ﬁbrils. (d) HR-TEM images of hIAPP aggregates. Although the oligomerization occurs in all of
the 3 h-incubated hIAPP samples, only Cu(II)-mediated oligomers are stable after 6 h incubation. Zn(II)-mediated oligomers are mixed with
ﬁbrillar aggregates after 6 h incubation. Oligomeric species are marked with yellow boxes.
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View Article OnlineDivalent metal ions [e.g., Cu(II), Zn(II)] have been accepted as
a major cause of the formation of hIAPP oligomers, in that both
metal ions may suppress hIAPP brillation and form stable
oligomers.7,13–16 Since the interaction site of Cu(II) or Zn(II) on
hIAPP has been identically proposed to His18,14,17 cooperative
and competitive eﬀects of these metal ions are also expected as
observed in amyloid-b.18 Cu(II) and Zn(II) also play an important
role in the pathology of T2DM. Alteration in Cu(II) metabolism
has been related to T2DM based on several clinical reports
demonstrating an elevated level of Cu(II) in the serum and
plasma of patients with diabetes mellitus.19–25 In particular, the
serum Cu(II) level is associated with glycemic control in T2DM
patients.26 One in vivo study indicated that gastrointestinal
copper absorption is enhanced in diabetic rats.27 It is, however,
still unclear whether the Cu(II) level is elevated in pancreatic
cells of T2DM patients. Considering the fact that insulin
exocytosis occurs near blood vessels,28 an increased Cu(II) level
in serum would facilitate interactions between Cu(II) and hIAPP,
which is co-secreted with insulin.29 In addition, other studies
suggest that the interaction of hIAPP with Cu(II) could induce
the production of toxic aggregates and ROS.13 Zn(II) could be
involved in the stabilization and release of insulin in the b-cells
of the pancreas,30 the organ with the highest level of this metal
ion; indeed, Zn(II) is found at millimolar concentration in b-cell
granules.31 Taken together, the interactions between hIAPP and
these divalent ions seem to be closely linked to the formation of
toxic peptide aggregates.
Herein, we report the structures of metal-free and Cu(II)-/
Zn(II)-associated hIAPP oligomers, as well as mechanistic detailsThis journal is © The Royal Society of Chemistry 2016of their assembly using multiscale biophysical approaches,
including circular dichroism (CD) spectroscopy, transmission
electron microscopy (TEM), electrospray ionization-ion
mobility-mass spectrometry (ESI-IM-MS), gel electrophoresis
with Western blot, small-angle X-ray scattering (SAXS), and
molecular dynamics (MD) simulations. Overall, the results from
our investigations of metal-free and metal-associated hIAPP
oligomerization present the structural features and assembly
mechanisms of early-stage amyloid oligomers, advancing our
understanding of how hIAPP–metal interactions could direct
peptide assembly that is relevant to toxicity.Results and discussion
Oﬀ-pathway oligomerization of hIAPP mediated by Cu(II)
We rst investigated hIAPP brillation in the absence and
presence of Cu(II) and Zn(II) using CD spectroscopy (Fig. 1b).
The secondary structure of metal-associated hIAPP and metal-
free hIAPP was dominantly random coil at the initial stage. Aer
6 h incubation, suppression of hIAPP brillation in the pres-
ence of Cu(II) was observed under our experimental conditions
(20 mM HEPES, pH 7.5, 20 mM NaCl; 37 C; constant agitation
at 300 rpm). The secondary structure of hIAPP remained as
random coil in the presence of Cu(II), whereas high b-sheet
propensity was observed in Zn(II)-treated and metal-free hIAPP.
We also examined the morphology of the 6 h-incubated hIAPP
aggregates using TEM with 80 keV electron beam energy
(Fig. 1c). The morphology of Cu(II)-associated hIAPP aggregates
was small and rounded, distinct from that of amyloid brils.Chem. Sci., 2016, 7, 5398–5406 | 5399
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View Article OnlineThis is consistent with the previous studies which reported the
Cu(II)-mediated formation of hIAPP aggregates with only a few
tens of nanometers in diameter.7,13 In contrast to the Cu(II)-
treated form, Zn(II)-treated and metal-free hIAPP assembled
into brils aer 6 h of incubation (Fig. 1c). We further examined
the morphology of hIAPP aggregates using high-resolution TEM
(HR-TEM) with 200 keV electron beam energy to obtain more
detailed images of hIAPP aggregates. Oligomeric species were
commonly found in all of the hIAPP samples aer 3 h of incu-
bation (denoted with yellow boxes in Fig. 1d). However, the
production of the brillar aggregates was suppressed by the
addition of Cu(II), whereas the oligomeric species in Zn(II)-
treated and metal-free conditions were converted to brillar
aggregates aer 6 h incubation. These results imply that Cu(II)
mediates the generation of oﬀ-pathway hIAPP oligomers and
maintains the random coil structure of hIAPP.
The highly toxic eﬀects of Cu(II)-associated hIAPP oligomers
have been previously reported.7,13 Chen and co-workers reported
that Cu(II) increased the cytotoxicity of hIAPP aggregates by
facilitating apoptosis-promoting eﬀects.7 In particular, they
suggest that Cu(II)-triggered ROS could disrupt mitochondria
and then initiate apoptosis in pancreatic cells. We conducted
a toxicity study using rat insulinoma-1 (INS-1) pancreatic b-cells.
The results of this experiment also support the toxicity of Cu(II)-
associated hIAPP oligomers. Higher toxicity of Cu(II)-associated
hIAPP oligomers, generated by preincubation of Cu(II) and
hIAPP, was observed compared to both metal-free hIAPP and
Zn(II)-associated hIAPP (Fig. 2a). When INS-1 pancreatic b-cells
were treated with Cu(II)-associated hIAPP oligomers and incu-
bated for diﬀerent durations (24–72 h), their cytotoxicity
increased in a time-dependent manner. Additionally, a dye
leakage assay was also carried out to verify the membrane-
disruption eﬀects of Cu(II)-associated hIAPP oligomers.
Previous studies suggest that hIAPP oligomers could induce
membrane disruption in a manner similar to antimicrobial
peptides.8,32,33 As shown in Fig. 2b, hIAPP preincubated withFig. 2 Cytotoxicity investigations of metal-free and metal-mediated hIAP
ions for 3 h in rat INS-1 pancreatic b-cells, observed over 24–72 h. Con
normalized with the background for each condition (e.g. toxicity of Cu(II)-
Cu(II) and Zn(II) is suggested in Fig. S1.† *According to inductively coupled
includes ca. 0.6 and 6.5 mM of Cu and Zn, respectively, and the INS-1 cell
that metal-associated hIAPP could exist even in our metal-free condition
without pre-incubation for 3 and 6 h. Conditions: [hIAPP] : [vesicles] ¼
a ratio of 7 : 3).
5400 | Chem. Sci., 2016, 7, 5398–5406Cu(II) for 3 h was observed to impair membrane integrity by ca.
70%, whereas metal-free or Zn(II)-associated hIAPP aggregates
triggered only 10–30% dye leakage. Even aer 6 h of incubation,
Cu(II)–hIAPP presented higher dye leakage eﬀects (ca. 65%)
compared to metal-free and Zn(II)-treated hIAPP. Thus, our
results suggest that when Cu(II) is present, hIAPP monomers are
redirected to form oﬀ-pathway aggregates which exert increased
toxicity towards pancreatic b-cells and cause deterioration of
membrane integrity.Structural analyses of metal-free and metal-associated hIAPP
monomer
To understand the structural features of hIAPP monomers, we
used ESI-IM-MS that provides collision cross-section (UD) and
the mass-to-charge ratio (m/z) of ions. ESI-IM-MS has been used
to probe individual conformers of intrinsically disordered
proteins (IDPs), and to determine their assembly dynamics
based on variations of UD in the gas phase.34–36 ESI-IM-MS has
also been employed to understand the conformational
dynamics of metal-free hIAPP and its assemblies.37,38 We rst
probed the complex formation between hIAPP and metal ions
upon the treatment with metal ions (Fig. 3a). The mass spectra
of hIAPP without metal ions dominantly exhibit a 4+ charged
state. When Cu(II) and Zn(II) ions were added to hIAPP solution,
1 : 1 metal–protein complexes were observed with similar
charge state distributions. In the case of Cu(II), the holo form
([M + Cu + 2H]4+; m/z 992.2) shows higher abundance than the
apo form ([M + 4H]4+; m/z 976.8). On the other hand, for Zn(II),
the apo form was higher in abundance than the holo form ([M +
Zn + 2H]4+; m/z 992.7). This result is likely to reect the higher
aﬃnity of Cu(II) toward hIAPP than that of Zn(II) toward hIAPP
(for Cu(II), Ka, ca. 8.9  107 M1; for Zn(II), Ka, ca. 9.1  105 M1;
Fig. S2†).
The binding sites of Cu(II) and Zn(II) on hIAPP were identied
using electron capture dissociation (ECD).39,40 ECD analysis
indicates that the metal ions are located in the central region ofP oligomers. (a) Toxicity of hIAPP preincubated with and without metal
ditions: [hIAPP] ¼ 10 mM; [CuCl2 or ZnCl2] ¼ 20 mM. Cell viability was
treated hIAPPwas normalized with the toxicity of Cu(II)). Cell viability for
plasma mass spectrometry analysis, the medium used for cell culture
lysates includes ca. 0.7 mM and 1.8 mM of Zn, respectively. This indicates
, inducing toxicity in living cells. (b) Dye leakage test for hIAPP with or
1 : 100 ([hIAPP] ¼ 2 mM; vesicles are composed of POPS and POPC at
This journal is © The Royal Society of Chemistry 2016
Fig. 3 Molecular interactions and conformational changes in metal-associated hIAPP. (a) ESI-MS spectra for monomeric hIAPP with and without
metal ions. Conditions: [hIAPP]¼ 5 mM; [CuCl2 or ZnCl2] ¼ 10 mM; 100 mM ammonium acetate. The average mass for hIAPP is indicated asM. (b)
IM-MS spectra for +4-charged metal-associated and metal-free hIAPP. (c) Representative MD-simulated structures of hIAPP monomer in
solution and the gas phase.
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View Article OnlinehIAPP that includes His18 (Fig. S3†). This result is consistent
with previously reported binding sites for Cu(II)13,17 and Zn(II).14
We further tested the role of His18 in metal binding by varying
the pH of hIAPP solution from 7 to 5. The His residue in
a protein is protonated at pH 5 (pKa  6.1), and the protonation
inhibits the interaction between His and metal ions.14 As ex-
pected, the formation of hIAPP–metal complexes dramatically
decreases at pH 5 (Fig. S4†). These results further support that
the molecular interactions between hIAPP and metal ions occur
at His18 of hIAPP.
We also investigated the conformational features of metal-
associated and metal-free hIAPP monomers (Fig. 3b). Ion
mobility spectra of +4-charged hIAPP ions are plotted withThis journal is © The Royal Society of Chemistry 2016calibrated UD values on the x axis (Fig. S5†). The distributions
indicate that two major conformers of hIAPP [i.e., the compact
(UD¼ 642–648 A˚2) and extended (UD¼ 761 A˚2) conformers] were
present in both metal-associated and metal-free states. The
relative abundance of the compact conformer in Cu(II)-bound
and metal-free hIAPP ions is higher than that of the extended
conformer. In contrast, for Zn(II)-bound hIAPP ions, the abun-
dance of the extended conformer is higher than that of the
compact conformer. Notably, hIAPP associated with various
other metal ions (Ca2+, Mg2+, and 2Na+) also preferred the
extended conformation to the compact conformation as indi-
cated by the results of ESI-IM-MS (Fig. S6†). Previously, Bowers
and co-workers suggested that electrostatic repulsion betweenChem. Sci., 2016, 7, 5398–5406 | 5401
Fig. 4 Assembly mechanism of hIAPP oligomers. (a) ESI-MS for olig-
omeric hIAPP incubated with and without metal ions. z-Charged n-
mer ion is denoted as nz+, and left superscript with asterisks k (k*)
indicates k metal ions included in the oligomers. (b) Correlations
between oligomeric state (n) and UD of n
n+1 ions for experimentally
detected oligomers. Calibration curve of the oligomers is available in
Fig. S13.†
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View Article Onlinecharged residues could stabilize the extended conformer of
metal-free hIAPP in the gas phase.36 We also infer that the
extended conformer of metal-associated hIAPP ions is stabilized
by electrostatic repulsion during the transfer of ions from
solution to the gas phase.
The prevalence of compact conformers for Cu(II)-associated
hIAPP ions is likely to originate from its distinct coordination
property. The previous EPR study on hIAPP–Cu(II) suggested
that Cu(II) could be coordinated to hIAPP in a 3N1O form with
two deprotonated nitrogens in the amide backbone of Ser19
and Ser20, a nitrogen donor atom in the His18 residue, and an
oxygen donor atom of Ser20.17 Such residues composed of two
negatively charged and two polar atoms stabilize the positive
charge of Cu(II). Thus, it is expected that the coordinated Cu(II)
cannot exert suﬃcient electrostatic repulsion to alter the
structures of hIAPP in the gas phase.
To understand the role of metal ions in hIAPP structures, we
performed molecular dynamics (MD) simulations in both
solution and the gas phase. Replica exchange MD (REMD)
simulations of hIAPP monomer in implicit solvent were rstly
performed for eﬀective sampling of metal-free hIAPP confor-
mation in solution. Structures with a residual a-helix (Fig. 3c)
were dominant in the structural distribution of hIAPP (Fig. S7†),
in accordance with a previous study.36 Another structural family
with a residual b-strand36 was also observed at a lower abun-
dance (Table S1†). MD simulations of these structures were
further performed in the gas phase (Fig. S8†). The simulations
yielded the structures with theoretical UD corresponding to
experimental UD of the compact conformer. This result implies
that the compact conformer has most likely originated from the
structures in solution. We further conducted simulated
annealing in the gas phase to generate and understand candi-
date structures of the extended conformer. We chose the lowest-
energy structures which have theoretical UD values that agree
(3%) with the experimental UD value of the extended
conformer (Fig. S9†). The most stable conformation for the
extended conformer is the extended b-strand structure with the
N-terminal and C-terminal regions aligned in an anti-parallel
orientation.
Based on the binding sites deduced from ECD-MS and
literature reports,13,14,17 metal-associated hIAPP was also simu-
lated using MD. We ligated a metal ion to the most abundant
structures in metal-free hIAPP and simulated the peptide in an
explicit solvent. Compared to metal-free hIAPP, metal-associ-
ated hIAPP monomers display similar structures, but metal-
hIAPP coordination at His18 causes a local change around
His18 (Fig. 3c). MD simulations of metal–hIAPP complexes in
the gas phase generate compact ions with small UD, suggesting
that the compact conformers observed in IM-MS were trans-
ferred from the structure in solution. Analogously to metal-free
hIAPP ions, it was necessary to sample candidate structures of
gas-phase hiAPP–metal complex ions using simulated anneal-
ing (Fig. S10 and S11†). In the extended conformer of the
hIAPP–Zn(II) complex, the local structure around His18 was
rearranged to stabilize Zn(II). In the case of Cu(II), while hIAPP–
Cu(II) coordination maintains the local structure around His18,
carbonyl groups in the backbone of the C-terminal region5402 | Chem. Sci., 2016, 7, 5398–5406stabilize the charged Lys1 and N-terminus, similar to the metal-
free hIAPP ions.
The structural diﬀerence in the extended conformer has its
origin in the 3N1O coordination of hIAPP–Cu(II) complexes. The
maximum charge of hIAPP–Cu(II) complexes is +3 in solution
(N-terminus, Lys1, and Arg11). Even if one of the two deproto-
nated nitrogens in amide backbone is reprotonated to yield +4
ion in the gas phase, the Cu(II)-coordinated region of hIAPP
would remain as a +1 charged state, which is analogous to the
protonated His18 in metal-free hIAPP. In contrast, for the
hIAPP–Zn(II) ion, only two sites from among the possibleThis journal is © The Royal Society of Chemistry 2016
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View Article Onlineprotonation sites should be protonated to yield the +4 ion.
Consequently, the distribution of positive charges in hIAPP
monomer causes the structural diﬀerences in the extended
conformer. To summarize, the molecular interaction between
Cu(II) and hIAPP causes the regional localized change in hIAPP
structure in solution and the gas phase.Assembly mechanisms of small-sized hIAPP oligomers in
metal-associated and metal-free states
We investigated the oligomerization mechanisms of metal-
associated and metal-free hIAPP incubated in solution using
ESI-IM-MS. The mass spectra of incubated hIAPP show that
metal-associated and metal-free hIAPP oligomers form up to
tetrameric and octameric states, respectively (Fig. 4a). Although
broad peaks corresponding to pentameric and hexameric states
of hIAPP were also observed in ESI-MS of metal-treated hIAPP,
we excluded them from the identied peak lists due to the low
abundance of metal-specic peaks. Then we only treated metal-
specic peaks with the high abundance (Fig. S12†). The n-mer
hIAPP ions with n + 1 charge state were dominantly observed in
both metal-associated and metal-free state. Other charge states
(n + 2 and n + 3) of hIAPP n-mer were also observed at lower
abundance. Cu(II)-associated hIAPP oligomers mainly exhibit
1 : 1 metal-to-peptide stoichiometry, whereas a single Zn(II) ion
binds to hIAPP oligomers (Fig. S12†). As shown in the mono-
meric state, the 1 : 1 metal-to-peptide ratio in Cu(II)-associated
hIAPP oligomer implies that Cu(II) maintains its high aﬃnity
toward each monomer within the oligomer. For Zn(II), it is ex-
pected that multiple interactions of a single Zn(II) ion with
hIAPP induce oligomer assembly, as suggested in a previous
study.16
Experimental UD values for n-mer hIAPP with n + 1 charge
state were plotted against n in Fig. 4b. The UD values of metal-Fig. 5 Size analyses of hIAPP oligomers. (a) Oligomerization monitored u
(b) Solution SAXS analysis of metal-mediated and metal-free oligomers
suggested with Rg values (up). SAXS envelope structures reconstructed f
individual oligomers (down).
This journal is © The Royal Society of Chemistry 2016free oligomers generally agree with those of metal-free oligo-
mers previously reported.38 Up to the hexameric state of metal-
free hIAPP, their UD values can be tted to a linear function and
a two-thirds power function (Table S2†). The linear model
indicates that monomers are aligned in the one direction.41 The
two-third power function indicates that monomers are iso-
tropically assembled to globular conformations.41 Previous
studies using ESI-IM-MS suggest that metal-free hIAPP are
linearly38 or isotropically42 assembled. Our tting results show
that the isotropic growth is slightly better matched to the
experimental UD values. Both models could be possible
scenarios for hIAPP oligomerization, however.
The UD values of both metal-associated and metal-free olig-
omers show a similar trend up to the tetramer stage. It is
noteworthy that a minor change in the conformation of Cu(II)-
associated dimer was observed in n + 3 charge state (Fig. S14–
S17†). In the dimer with +3 charge state, four distinct peaks
were observed in the arrival time distributions (Fig. S15†). The
peak at the center shows the UD value similar to that of the
metal-free dimer, while UD values of the other peaks indicate
the presence of small and large conformers. This implies that
the overall sizes of the oligomer ions are similar at low charge
states in the gas phase, but a minor change is observable at high
charge states. Such a loss of conformational properties in metal-
associated oligomers can be attributed to the gas-phase collapse
at low charge state.43
In metal-free oligomers, a discrete trend from the linear and
isotropic models is observed in heptamer and octamer forms.
This may be explained by a transition from the isotropic or the
linear assembly model to another growth model. An earlier
study suggests that there is a transition from the isotropic to the
linear growth during the self-assembly of peptides.41 Although
metal-containing oligomers larger than pentamers were notsing gel electrophoresis with Western blotting (amylin antibody H-50).
. p(r) from averaged scattering patterns of each oligomer solution is
rom p(r) (mid) are suggested with the representative TEM image of the
Chem. Sci., 2016, 7, 5398–5406 | 5403
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View Article Onlineobserved, it is expected that metal ions would induce a confor-
mational change as the size of the oligomer increases.
In summary, during the assembly of small-sized oligomers,
metal-associated and metal-free oligomers form through
a similar growthmodel (linear or isotropic) up to tetramer stage.
Aer the tetramer state, however, the molecular interactions
between metal ions and hIAPP may divert the assembly process
to a diﬀerent pathway from that of the metal-free state.Characterization of large-sized oligomers for metal-associated
and metal-free hIAPP
To gain a better understanding of metal-mediated hIAPP
assemblies from small-sized oligomers to large-sized oligomers,
gel electrophoresis with Western blotting (gel/Western blot)
using a H-50 antibody was performed for hIAPP samples incu-
bated with and without Cu(II) or Zn(II). To obtain the soluble
oligomer fraction, we prepared the supernatant from the incu-
bated solution using centrifugation. The gel/Western blot
analysis of the supernatant, showed a wide distribution of
bands ranging from 4 to 60 kDa (1–15 mers) in both metal-
associated and metal free hIAPP (Fig. 5a). Cu(II)-treated hIAPP
showed distinct bands around 30 kDa, whereas Zn(II)-treated
and metal-free hIAPP displayed bands around 15 kDa. This
result implies that the molecular interaction of hIAPP with
Cu(II) could induce the formation of soluble oligomers with
diﬀerent assembly states compared to Zn(II)-treated and metal-
free states.
The supernatant of the incubated hIAPP solution was further
analyzed using solution SAXS. We obtained scattering patterns
of the soluble fraction of the solution incubated with and
without metal ions (Fig. S18a†). Then, the radius of gyration (Rg)
was estimated from Guinier t analysis (Fig. S18b†). Based on
the Rg values and scattering patterns, the pair distance distri-
bution function (p(r)) was generated using program GNOM44 to
obtain a three-dimensional envelope structure45 of hIAPP olig-
omers in the supernatant (Fig. 5b). The Rg values of each olig-
omer increase in the following order: Cu(II) (44.7 A˚) < Zn(II) (51.3
A˚) < metal-free (64.7 A˚). The maximum distances (Dmax) in p(r)
and the dimensions of SAXS envelopes also increase in the same
order as Rg. SAXS envelopes of metal-containing and metal-free
oligomers were reconstructed from the p(r) of the oligomers.
Although SAXS envelopes were deduced from the ensemble
measurement of diverse oligomeric states contained in the
sample, we assumed that SAXS scattering patterns would reect
the size of the abundant species in the supernatant. We
attempted to directly compare the envelopes with magnied
TEM images of hIAPP oligomers. When compared with TEM
images, SAXS envelopes show a good agreement with negatively-
stained oligomers. This result supports the concept that SAXS
envelopes partially represent the individual oligomers in the
TEM images despite the averaging of structural information
(Fig. 5b), as suggested in the previous study of amyloid
oligomers.46
While Cu(II)-associated hIAPP shows a distinct band around
30 kDa by gel/Western blot, it exhibits the smallest Rg value in
SAXS measurement. In contrast, Zn(II)-associated hIAPP and5404 | Chem. Sci., 2016, 7, 5398–5406metal-free hIAPP show oligomers of approximately 15 kDa in
gel/Western blot, but Rg values of Zn(II)-treated and metal-free
hIAPP are greater than those of Cu(II)-treated hIAPP. We
suppose that Cu(II) stabilizes the assembly state of hIAPP into
an intermediate state between small oligomeric state and
brillar aggregates. On the other hand, such intermediate
species are not found in the gel/Western blot and SAXS of Zn(II)-
associated and metal-free oligomers which are readily con-
verted into brillar aggregates.Distinct features in the oligomerization of Cu(II)-associated
hIAPP
In our studies, Cu(II)-associated hIAPP formed oﬀ-pathway
aggregates that were stabilized as soluble oligomers. We rst
conrmed Cu(II)-associated oligomers by TEM (Fig. 1c and d).
SAXS envelope obtained from the Cu(II)-treated hIAPP solution
further supports the presence of the soluble oligomers similar
to those in the TEM images (Fig. 4b). These oligomeric species
showed relatively high toxicity in pancreatic b-cells, compared
to Zn(II)-containing and metal-free forms (Fig. 2a). The disrup-
tive eﬀect of Cu(II)-containing hIAPP on the membrane of lipid
vesicles was especially signicant (Fig. 2b).
Fibrillation of hIAPP occurs through the sequential process
of (i) formation of an a-helical intermediate,47 (ii) b-turn
formation at the central region of hIAPP,48 and (iii) the assembly
of a b-sheet rich bril.49 Protonation or Zn(II) coordination at
His18 of the central region of the polypeptide has an inhibitory
eﬀect on the process of the intermediate formation due to
following reasons. First, electrostatic repulsion by protonation
at His residues disrupts protein–protein interaction of hIAPP.50
Second, Zn(II) coordination stabilizes the structure of oﬀ-
pathway intermediates.16 The 3N1O coordination of Cu(II)
around His18 also restricts the conformational change of the
hIAPP structure.17 Our ESI-IMS-MS results and MD simulations
of hIAPP monomer (Fig. 3) also suggest that its coordination to
Cu(II) with the relatively high stability of hIAPP–Cu(II) complexes
could restrict the change of the regional structure of hIAPP
monomer in both solution and the gas phase. Moreover, the
stoichiometry of 1 : 1 metal to peptide in Cu(II)-containing
oligomers (Fig. 4a) implies that the interaction with Cu(II) is still
present in the oligomeric states of hIAPP.
We infer that such molecular interactions between hIAPP
and Cu(II) are crucial for the formation of oﬀ-pathway aggre-
gates and their toxicity. CD spectra and TEM images (Fig. 1)
showed that Cu(II)-associated oligomers would have a random
coil propensity rather than a b-sheet propensity. These facts
imply that while hIAPP–Cu(II) interaction suppresses the
formation of hIAPP brils, the hydrophobic regions in hIAPP
can interact with each other via non-specic intermolecular
hydrophobic interactions. Most of the hIAPP sequences except
for a few residues in the N-terminal region are composed of
highly hydrophobic residues that participate in b-sheet align-
ment of hIAPP brils. These hydrophobic regions of hIAPP in
Cu(II)-containing oligomers may have random conformations
rather than aligned structures. In general, b-sheet aligned brils
have less toxic and deleterious eﬀects on membranes thanThis journal is © The Royal Society of Chemistry 2016
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View Article Onlinesoluble amyloid oligomers with more exposed hydrophobic
regions.2,8,32 Thus, the relatively high toxicity of Cu(II)-mediated
oligomers seems to be correlated with the exposure of hydro-
phobic residues in a random coil state. As a result, Cu(II)
binding to hIAPP with relatively high aﬃnity (Ka, ca. 10
8 M1)
could cause the self-assembly of hIAPP with random coil
structures, thereby inducing the formation of toxic aggregates.Conclusions
The oligomerization process of metal-treated and metal-free
hIAPP has been characterized using multiscale biophysical
techniques. The structural characteristics of metal-associated
and metal-free hIAPP oligomers were examined using CD, TEM,
and SAXS. We conrmed the toxicity of these oligomers using
the MTT assay and dye leakage assay. The molecular interac-
tions of metal-containing hIAPP, and the growth mechanisms
of the small-sized oligomers were investigated using ESI-IM-MS
and MD simulations. Based on the results obtained with these
multiple biophysical methods, we suggest that the molecular
interaction between hIAPP and Cu(II) stabilizes the secondary
structure of the oligomers into random coil, thereby inducing
the formation of toxic and oﬀ-pathway aggregates. Our ndings
with mechanistic details on toxic assemblies of Cu(II)-contain-
ing hIAPP may provide insights into developing a rational
strategy for the design of eﬀective therapeutic agents (e.g., metal
chelating agents51,52). Moreover, our approaches presented
herein can be generally applied to identify the structural prop-
erties and oligomeric assemblies of other amyloidogenic
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